高级检索
当前位置: 首页 > 详情页

Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome A Randomized Clinical Trial

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin 150040, Peoples R China [2]World Federat Chinese Med Societies, Comm Reprod Med, Beijing, Peoples R China [3]Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden [4]Xuzhou Maternal & Childrens Hosp, Outpatient Dept, Xuzhou, Peoples R China [5]Dalian Maternal & Childrens Ctr, Ctr Reprod Med, Dalian, Peoples R China [6]Tanggu Dist Maternal & Childrens Hosp, Dept Infertil, Tianjin, Peoples R China [7]Shanxi Prov Hosp Chinese Med, Dept Obstet & Gynecol, Taiyuan, Peoples R China [8]Huaian Maternal & Childrens Hosp, Ctr Reprod Med, Huaian, Peoples R China [9]Suzhou City Hosp Chinese Med, Dept Gynecol, Suzhou, Peoples R China [10]Jiangxi Univ Chinese Med, Hosp 2, Dept Gynecol, Nanchang, Jiangxi, Peoples R China [11]Guangzhou Med Univ, Affiliated Hosp 1, Dept Chinese Med, Guangzhou, Guangdong, Peoples R China [12]Liwan Dist Hosp Chinese Med, Dept Infertil, Guangzhou, Guangdong, Peoples R China [13]Anhui Univ Chinese Med, Affiliated Hosp, Dept Obstet & Gynecol, Hefei, Peoples R China [14]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Inst Integrated Tradit andWestern Med,Wuhan,Peoples R China [15]Wenzhou City Hosp Chinese Med, Dept Gynecol, Wenzhou, Peoples R China [16]Yuhuangding Hosp, Ctr Reprod Med, Yantai, Peoples R China [17]Daqing Longnan Hosp, Dept Obstet & Gynecol, Daqing, Peoples R China [18]Hunan Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China [19]Liaoning Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Shenyang, Peoples R China [20]Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Dept Gynecol, Tianjin, Peoples R China [21]Guangdong Prov Hosp Chinese Med, Dept Tradit Technol, Guangzhou, Guangdong, Peoples R China [22]Hangzhou City Hosp Chinese Med, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China [23]Zhejiang Prov Hosp Integrat Med, Ctr Reprod Med, Hangzhou, Zhejiang, Peoples R China [24]Daqing Oilfield Gen Hosp, Ctr Reprod Med, Daqing, Peoples R China [25]Hubei Prov Hosp Chinese Med, Dept Obstet & Gynecol, Wuhan, Peoples R China [26]Chinese Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China [27]Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China [28]Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China [29]Chinese Clin Trial Registry, Shenzhen, Peoples R China [30]Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China [31]Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China [32]Penn State Univ, Dept Obstet & Gynecol, Hershey, PA USA [33]Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA
出处:
ISSN:

摘要:
IMPORTANCE Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence. OBJECTIVE To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. DESIGN, SETTING, AND PARTICIPANTS A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1:1:1:1 ratio to 4 groups. INTERVENTIONS Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. MAIN OUTCOMES AND MEASURES The primary outcome was live birth. Secondary outcomes included adverse events. RESULTS Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea: 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising: 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). CONCLUSIONS AND RELEVANCE Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2015]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin 150040, Peoples R China [2]World Federat Chinese Med Societies, Comm Reprod Med, Beijing, Peoples R China
通讯作者:
通讯机构: [1]Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin 150040, Peoples R China [2]World Federat Chinese Med Societies, Comm Reprod Med, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:1 总访问量:411 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)